Hospitals sticking to the strict hand-me-down, highly profitable “COVID protocol” may have doomed a majority of admitted COVID-19 patients to death due to a perfect storm of institutional failure, a new study shows.

Hospital protocolists sticking to the strict hand-me-down highly profitable “COVID protocol” may have doomed a majority of admitted COVID-19 patients to death due to a perfect storm of institutional failure.

I first warned the U.S. Food and Drug Administration in early 2020 that because the commercial kits did not use internal negative controls there would be arbitrarily high COVID-19 false positive rates due to the abuse of non-quantitative PCR.

The majority of “cases,” I pointed out, would be false because the test was to be used as a screening device — and when you screen with an imperfect test when prevalence is low, you end up with more false positives than negatives in the set of positives.

Knowing that people who were symptomatic for respiratory infections would be among the most tested population and that Dr. Anthony Fauci’s medical approach to COVID-19 was to tell people to go home and get as sick as possible, it was readily clear that people would be dying due to lack of treatment for treatable conditions, like bacterial pneumonia and fungal infections in the lung.

Now a study from the National Institutes of Health-funded researchers in Chicago has found that unresolved respiratory infections — not necessarily those involved in SARS-CoV-2 — were present in people who failed to “respond” to mechanical ventilation.

The authors wrote:

“Recent data suggest that secondary pneumonia is present in up to 40% and pneumonia or diffuse alveolar damage is present in over 90% of autopsy specimens obtained from patients with acute SARS-CoV-2 infection (18).

“Consistent with these observations, we and others found high rates of ventilator-associated pneumonia (VAP) in patients with SARS-CoV-2 pneumonia requiring mechanical ventilation, suggesting that bacterial superinfections such as VAP may contribute to mortality in patients with COVID-19 (7, 19–22).

“These findings prompt an alternative hypothesis that a relatively low mortality rate directly attributable to primary SARS-CoV-2 infection is offset by a greater risk of death attributable to unresolving VAP (23).”

They concluded:

“These data suggest mortality associated with severe SARS-CoV-2 pneumonia is more often associated with respiratory failure that increases the risk of unresolving VAP and is less frequently associated with multiple-organ dysfunction.”

Unsurprisingly, the study found that people with bacterial pneumonia who were on ventilators had the highest mortality.

Although their analysis restricted consideration to bacterial pneumonia cases detected 48 hours after ventilation, they did not distinguish between undiagnosed cases of bacterial pneumonia upon admission and those acquired in-hospital (nosocomial infection).

The rate of co-infection is not clear either, due to insufficient testing for bacterial pneumonia in patients once diagnosed with COVID-19.

The study leads to the stunning potential that perhaps 58% of “COVID” cases were respiratory issues other than COVID-19 (43% bacterial pneumonia, 16% non-pathogen causes of respiratory failure). Treated as “COVID,” these patients were doomed to a fate of non-treatment due to mis- or under-diagnosis.

It is unclear what percentage of deaths attributed to COVID-19 could have been prevented via a standard therapy for bacterial pneumonia, but it is potentially very high.

Fauci’s preskription — sending patients home to do nothing — no corticosteroids, no antibiotics just in case it was bacterial — drove the COVID-19 death rate up far higher than it had to be.